The outcome of transobturator cystocele repair using biocompatible porcine dermis graft: our experience with 32 cases

This study aims to evaluate the outcome of cystocele repair using Perigee® with biocompatible matrix (InteXen®). After IRB approval, a retrospective chart review of patients who underwent Perigee®/InteXen® repair was done. Success was defined as a postoperative anatomical stage 0 or I using POP-Q system. Thirty two patients were included with 14 (43.75%) who had failed previous repair. Preoperatively, eight patients (25%) had stage II cystocele, 21 (65.6%) had stage III, and three (9.4%) had stage IV. Twenty six patients (81.25%) were available for a median follow up of 8.72 (6–31) months that showed success in 25 patients (96%) with 14 (54%) having stage 0 and 11 (42%) having stage I. Complications included bladder perforation (n = 1), incidental cystotomy (n = 1), mesh erosion (n = 1), and wound dehiscence (n = 1). This study suggests cystocele repair using Perigee® with InteXen® has a high short-term success with lower morbidity.